By a News Reporter-Staff News Editor at AIDS Weekly Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. According to news reporting from Durban, South Africa, by NewsRx journalists, research stated, "The chemokine ligand 21 is a cytokine that attracts CCR7-positive cells to the T cell zone of lymph nodes by directional migr
By a News Reporter-Staff News Editor at Pharma Business Week Lipocine Inc., a specialty pharmaceutical company, announced that it has received a Complete Response Letter from the United States Food and Drug Administration regarding its New Drug Application for TLANDO?, the Company's oral testosterone product candidate for testosterone replaceme
By a News Reporter-Staff News Editor at Clinical Trials Week Medicure Inc. is pleased to announce the commencement of enrollment in SAVI-PCI a prospective, multicenter, randomized clinical trial of its commercial product, AGGRASTAT , in the United States. The first sites initiated in the SAVI-PCI study are the Centennial Heart and Vascular Cent
New Diabetes Mellitus Management Study Findings Have Been Reported by Investigators at Copenhagen University Hospital. According to news reporting originating in Copenhagen, Denmark, by NewsRx journalists, research stated, "Pancreatogenic diabetes develops in patients undergoing total pancreatectomy and complicates post-surgical management.
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Grueneberg, Dorre A.; Kalid, Ori; Xian, Jun; Rajur, Sharanappa B.; Kim, Hwa-Ok; Neelagiri, Venugopal Rao; Salgaonkar, Paresh; Sethumadhavan, Divakaramenon; Moon, Chaeho; Neelagiri, Madhavi, filed on March 13, 2014, was published online on May 8, 2018, according
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Chen, Guohua; Ding, Zhongli; Ghartey-Tagoe, Esi; Shastry, Ashutosh; Worsham, Robert Wade; Singh, Parminder, filed on March 14, 2014, was published online on May 8, 2018, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents
By a News Reporter-Staff News Editor at Pharma Business Week Sanofi has been issued patent number 9962499, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Roberts, Gareth; Ward, Chris; Ekman, Matthew. This patent was filed on April 13, 2016 and was published online on May 8, 2018.
By a News Reporter-Staff News Editor at Clinical Trials Week New research on Drugs and Therapies- Drug Delivery Systems is the subject of a report. According to news reporting out of Cairo, Egypt, by NewsRx editors, the research stated, "Cancer was and still a very stressful and urgent disease condition representing a leading cause of death in de
Takeda Pharmaceutical Company Limited today announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming medical meetings: the 54th Annual Meeting of the American Society of Clinical Oncology, June 1-5 in Chicago and the 23rd Congress of the European Hematology Association, June 14-17 in Stockholm.
-Adherium, a digital health company that improves medication adherence and patient outcomes, announced the extensive use of its Hailie technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal of Medicine and will be presented this weekend at the American Thoraci
Albany, NY 05/18/2018 A new Transparency Market Research report states that the global implantable drug delivery devices market stood at US $11.6 bn in 2011 and is predicted to reach US $21.1 bn by 2018. It is predicted to expand at a CAGR of 8.80% from 2012 to 2018. The title of the report is "Implantable Drug Delivery Devices Market- Global
Pfizer has reported positive top-line results from a phase 3 study, which assessed the use of Lyrica oral solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age. The study was a post-marketing requirement by the U.S. Food and Drug Administration. Pfizer internal medicine
Adherium, a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it s Hailie? technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal of Medicine and will be presented this weekend at the American
The Company had the Type A Meeting to discuss the complete response letter dated December 21, 2017 that the FDA issued in connection with the June 26, 2017 New Drug Application resubmission for the Company's investigational low dose, non-daily combination hormonal contraceptive patch, Twirla. The Company received the final meeting minutes from the
Agile Therapeutics, Inc.,, a women s healthcare company, today announced the content of the official minutes from its Type A meeting with the U.S. Food and Drug Administration held on April 16, 2018 to discuss the complete response letter issued by the FDA on December 21, 2017 relating to the New Drug Application for Twirla, the Company s i
By a News Reporter-Staff News Editor at Drug Week Amneal Pharmaceuticals has launched vigabatrin for oral solution USP, a generic equivalent for Sabril . Amneal has also filed an ANDA with US FDA for the tablet form of vigabatrin. Annual U.S. sales of vigabatrin for oral solution were $318 million, according to March 2018 IQVIA? market data.
Avadel Pharmaceuticals plc, Avadel or the Company, will release research findings from the Phase III clinical trials of AV002 at the American Urological Association Annual Meeting in San Francisco on May 20, 2018 that demonstrate elderly nocturia patients treated with AV002 NOCTIVA? Nasal Spray, an emulsified microdose of desmopr
-The market for connected drug delivery devices is foreseen to witness a stellar growth rate of 25.6% from 2015 to 2027 rising to a valuation of US$ 1,304.7 Mn from US$ 132.2 Mn in 2017. According to the analyst of Future Market Insights, the leading manufacturers of connected drug delivery devices are focusing collaboration with the software compa
Albany, NY 05/18/2018 Transparency Market Research has published a new report titled "Drug Delivery System Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Rise in R&D investme
Albany, NY 05/18/2018 Transparency Market Research has published a new report titled "Gene Delivery System Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce advanced technologies for drug delivery systems in North America and Europe; therefore, these regions are likely to accou
Albany, NY 05/18/2018 Market Research Report Search Engine recently announced the addition of a new research study to its comprehensive collection of research reports. Since the first formulation of intravenous immunoglobulin that gained FDA approval back in 1980 s, the concept has been harnessed relentlessly in the last three decades and adv
-Insmed Incorporated, a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the appointment of Leo Lee to its Board of Directors. Mr. Lee has more than 21 years of experience in the pharmaceutical industry in Japan; most recently at Merck KGaA, a global pharmaceutical company, where he served
Investigators at University of Toronto Zero in on Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. The news reporters obtained a quote from the research from the University of Toronto, "However, in the design and evaluation of these...
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA (R) Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age. "The Phase 3 top-line results reinf